Connect with us

Life Sciences

AVITI™ in Action: Any Scale, Any Application

In this webinar, you’ll receive an in-depth introduction to Element Biosciences’ AVITI through an engaging panel discussion and audience Q&A session…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Panelists:

Anoja Perera
Anoja Perera
Director, Sequencing and Discovery Genomics
Stowers Institute for Medical Research
Adam Majot
Adam Majot, PhD
Principal Scientist
AgriPlex Genomics
Lutz Froenicke
Lutz Froenicke, PhD
Director of the DNA Technologies and Expression Analysis Cores
UC Davis Genome Center

Broadcast Date: October 10, 2023
Time: 10:00 am PT, 1:00 pm ET, 19:00 CET

Next-generation sequencing (NGS) has witnessed renewed excitement over the past couple years with several new platforms offering researchers unprecedented accuracy, speed, and flexibility. Launched in 2023 by Element Biosciences, AVITI FIT revolutionizes sequencing accessibility, delivering affordable, top-tier sequencing capabilities to more labs, including those with lower throughput needs, applications requiring longer read lengths, or limited budgets. Designed to make the Element AVITI System even more versatile, AVITI FIT is already active in the field and empowering a diverse group of labs to take control of samples, timelines, and budgets. 

In this webinar, you’ll receive an in-depth introduction to AVITI through an engaging panel discussion and audience Q&A session with a trio of NGS experts who have hands-on experience with AVITI. Our panelists will highlight the greater operational flexibility and expanded applications that AVITI FIT offers. You’ll learn how this technology sets AVITI apart and grants users across disciplines a competitive edge. 

Our three panelists are:     

  • Anoja Perera—Director, Sequencing and Discovery Genomics, Stowers Institute for Medical Research 
  • Adam Majot, PhD—Principal Scientist, AgriPlex Genomics       
  • Lutz Froenicke, PhD—Director, DNA Technologies and Expression Analysis Cores, UC Davis Genome Center 

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.


Produced with support from:

Element Bio logo

The post AVITI™ in Action: Any Scale, Any Application appeared first on GEN – Genetic Engineering and Biotechnology News.


Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending